Pages

Monday, March 28, 2022

Fourth Dose

"Moderately to severely immunocompromised individuals (12 to 17 year olds) who are eligible for a three-dose primary series are recommended to receive a booster dose (i.e. 4th dose) ≥6 months (168 days) after completion of the extended primary series or at an interval recommended by their provider.Feb 17, 2022"

https://www.google.com/search?q=norway&oq=norway&aqs=chrome..69i57j46i67i433j0i67i131i433j0i67l2j0i67i457j0i67i433l3.3682j0j7&client=ms-android-rogers-ca-revc&sourceid=chrome-mobile&ie=UTF-8

No comments:

Post a Comment